Emily Pinkerton
Nurse Practitioner, Obstetrics & Gynecology Lucedale, MS Nurse Practitioner
NPI 1992942353 CMS profile 10754493
P.O. Box 1007, Lucedale, MS 39452
General payments
$153
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Emily Pinkerton of Lucedale, MS is reported in the CMS Open Payments database as having received $153 across 6 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 38th percentile of Nurse Practitioner, Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $16 | 1 | |
| 2023 | General | $104 | 3 | |
| 2021 | General | $33 | 2 |
Beside peers
- Emily Pinkerton
- Nurse Practitioner, Obstetrics & Gynecology median
- Middle half of Nurse Practitioner, Obstetrics & Gynecology
- National median
In program year 2025, general payments to Emily Pinkerton were reported at $0. Among 1,030 Nurse Practitioner, Obstetrics & Gynecology profiles paid that year, the median was $151 and the middle half received between $51 and $371.
Show as a table
| Year | Emily Pinkerton | Nurse Practitioner, Obstetrics & Gynecology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $33 | $135 | $40–$338 | $132 |
| 2022 | $0 | $143 | $45–$386 | $149 |
| 2023 | $104 | $153 | $54–$411 | $160 |
| 2024 | $16 | $140 | $45–$326 | $164 |
| 2025 | $0 | $151 | $51–$371 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
130
Drug cost
$3,696
Branded share of claims
19.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Estradiol | Generic | 66 | $3,079 | |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | Brand | 12 | $157 | |
| Medroxyprogesterone Acetate | Generic | 13 | $129 | |
| Oxybutynin Chloride Er Oxybutynin Chloride | Brand | 13 | $116 | |
| Metronidazole | Generic | 12 | $115 | |
| Acyclovir | Generic | 14 | $99 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Obstetrics & Gynecology in Mississippi
Melissa Barnett
Nurse Practitioner, Obstetrics & Gynecology · Tupelo, MS
Stacey Kreher
Nurse Practitioner, Obstetrics & Gynecology · Bay St. Louis, MS
Kristen Duncan
Nurse Practitioner, Obstetrics & Gynecology · Southaven, MS
Linda Wright
Nurse Practitioner, Obstetrics & Gynecology · Clarksdale, MS
Amanda Sterling
Nurse Practitioner, Obstetrics & Gynecology · Gulfport, MS
Katherine Walters
Nurse Practitioner, Obstetrics & Gynecology · Jackson, MS
Related records
Nurse Practitioner, Obstetrics & Gynecology in Mississippi
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Obstetrics & Gynecology
Everyone recorded under this specialty, nationwide.
Doctors in Mississippi
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.